Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexketoprofen for Prevention of Rocuronium Injection Pain
NCT04582032Completed
- Sponsor
- Ankara City Hospital
- Start
- Nov 2020
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexketoprofen (2 arms), sponsored by Ankara City Hospital. Primary endpoint: The injection pain due to rocuronium at 1 month. Started Nov 2020; status: completed.
02
Drugs
dexketoprofen
Beyond the preview
Go deeper on NCT04582032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04582032.